Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
5.42 EUR | -1.28% | -5.74% | -18.37% |
Apr. 25 | Transcript : Nanobiotix S.A., Q4 2023 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Nanobiotix S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.37% | 277M | |
+1.77% | 42.86B | |
+44.98% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- NANO Stock
- News Nanobiotix
- Nanobiotix Says Pancreatic, Head, Neck Cancers Phase 1 Studies of NBTXR3 Show Higher Median Overall Survival